D
Denali Therapeutics (DNLI)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Denali Therapeutics (DNLI)
Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (... Read more
- USD13.84
- USD14.10
- USD13.70
- USD33.33
- -0.40%
- --
- 1.55M
- 2.0B
- 10.57
- -35.60%
Stock News
3 hours ago
The stock market has been running low on investors who want to sell. That might be starting to shift.
MarketWatch
5 hours ago
ONEOK Hasn't Recovered Yet Providing An Extended Opportunity For Investors
SeekingAlpha
5 hours ago
Silvercorp Metals: Silver Miner With An Attractive Valuation And Massive Growth Ahead - But There's A Catch
SeekingAlpha
5 hours ago
Osterweis Capital Management Q3 2025 Equity Outlook
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
